XML 74 R30.htm IDEA: XBRL DOCUMENT
v3.22.1

INCOME TAXES | 12 Months Ended
--- | ---
Dec. 31, 2021
INCOME TAXES | 25. INCOME TAXES The following table reconciles the expected income taxes at the Canadian statutory income tax rates to the amounts recognized in the statements of comprehensive loss for the years ended December 31, 2021, 2020 and 2019: SCHEDULE OF INCOME TAX
|  | December 31, 2021 |  |  | December 31, 2020 |  |  |  | December 31, 2019 |
Loss before income taxes |  | $ | 16,202,972 |  |  | $ | 8,015,813 |  |  | $ | 11,095,507 |
Canadian statutory rates |  |  |  |  |  |  | 27 | % |  |  | 27 | %
Expected income tax recovery |  |  | 4,196,600 |  |  |  | 2,164,000 |  |  |  | 2,996,000 |
Impact of different foreign statutory tax rates |  |  | 34,900 |  |  |  | - |  |  |  | - |
Non-deductible items |  |  | 116,400 |  |  |  | (687,000 | ) |  |  | (2,043,000 | )
Share issue costs |  |  | 887,600 |  |  |  | - |  |  |  | - |
Adjustments to prior years provision versus statutory tax returns |  |  | 376,500 |  |  |  | 189,000 |  |  |  | (388,000 | )
Differences between prior year provision and final tax return |  |  | (206,000 | ) |  |  | (535,000 | ) |  |  | (18,000 | )
Change in deferred tax asset not recognized |  |  | (5,406,000 | ) |  |  | (1,131,000 | ) |  |  | (547,000 | )
Income tax |  | $ | - |  |  | $ | - |  |  | $ | - |
Draganfly Inc. Notes to the Consolidated Financial Statements For The Year Ended December 31, 2021 Expressed in Canadian Dollars 25. INCOME TAXES (CONT’D) The Company’s unrecognized deductible temporary differences and unused tax losses for which no deferred tax asset is recognized consist of the following amounts: SCHEDULE OF DEFERRED TAXES
|  | December 31, 2021 |  |  | December 31, 2020 |  |  |  | December 31, 2019 |
Deferred income tax assets (liabilities): |  |  |  |  |  |  |  |  |  |  |  |
Share issuance costs |  | $ | 728,000 |  |  | $ | 30,000 |  |  | $ | - |
Non-capital losses |  |  | 7,043,000 |  |  |  | 3,656,000 |  |  |  | 2,439,000 |
Property and equipment |  |  | 449,000 |  |  |  | 457,000 |  |  |  | 581,000 |
Capital gain reserve |  |  | 74,000 |  |  |  | - |  |  |  | - |
Scientific Research and Experimental Development |  |  | 291,000 |  |  |  | 57,000 |  |  |  | 49,000 |
Total deferred income tax assets |  | $ | 8,585,000 |  |  | $ | 4,200,000 |  |  | $ | 3,069,000 |
Deferred income tax not recognized |  |  | (8,585,000 | ) |  |  | (4,200,000 | ) |  |  | (3,069,000 | )
Net deferred tax assets |  | $ | - |  |  | $ | - |  |  | $ | - |
The Company has non-capital loss carry forward of approximately $25,487,000 which may be carried forward to apply against future year income tax for Canadian income tax purposes, subject to the final determination by taxation authorities, expiring in the years 2036 to 2040.

X
- Definition The entire disclosure for income taxes. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 12 -IssueDate 2021-01-01 -Section Disclosure -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI -URIDate 2021-03-24 + Details
Name: | ifrs-full_DisclosureOfIncomeTaxExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration